Wir verwenden Cookies, um Ihnen ein optimales Webseiten-Erlebnis zu bieten. Dazu zählen Cookies, die für den Betrieb der Seite notwendig sind, sowie solche, die lediglich zu anonymen Statistikzwecken, für Komforteinstellungen oder zur Anzeige personalisierter Inhalte genutzt werden. Sie können selbst entscheiden, welche Kategorien Sie zulassen möchten. Bitte beachten Sie, dass auf Basis Ihrer Einstellungen womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen. Weitere Informationen finden Sie in unseren Datenschutzhinweisen .

Essentiell aktivieren/deaktivieren

Diese Cookies sind für die Funktionalität unserer Website erforderlich und können nicht deaktiviert werden.

Name	Webedition CMS
Zweck	Dieses Cookie wird vom CMS (Content Management System) Webedition für die unverwechselbare Identifizierung eines Anwenders gesetzt. Es bietet dem Anwender bessere Bedienerführung, z.B. Speicherung von Sucheinstellungen oder Formulardaten. Typischerweise wird dieses Cookie beim Schließen des Browsers gelöscht.
Name	econda
Zweck	Session-Cookie für die Webanalyse Software econda. Diese läuft im Modus „Anonymisiertes Messen“.

Statistik aktivieren/deaktivieren

Diese Cookies helfen uns zu verstehen, wie Besucher mit unserer Webseite interagieren, indem Informationen anonym gesammelt und analysiert werden. Je nach Tool werden ein oder mehrere Cookies des Anbieters gesetzt.

Name	econda
Zweck	Measure with Visitor Cookie emos_jcvid

Externe Medien aktivieren/deaktivieren

Inhalte von externen Medienplattformen werden standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der Zugriff auf diese Inhalte keiner manuellen Zustimmung mehr.

Name	YouTube
Zweck	Zeige YouTube Inhalte
Name	Twitter
Zweck	Twitter Feeds aktivieren

Forschung

Publikationen 2018

Eskilsson, E. ; Røsland, G. V. ; Solecki, G. M. ; Wang, Q. ; Harter, P. N. ; Graziani, G. ; Verhaak, R. G. W. ; Winkler, F. ; Bjerkvig, R. ; Miletic, H.
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.
Neuro-Oncology 20(6), 743 - 752 (2018) [10.1093/neuonc/nox191]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Karreman, M. A. (First author) ; Winkler, F. (Last author)
The mechanics of metastatic seeding.
Nature cell biology 20(8), 860 - 862 (2018) [10.1038/s41556-018-0162-8]2018 BibTeX | EndNote: XML, Text | RIS

Regnery, S. (First author) ; Adeberg, S. ; Dreher, C. ; Oberhollenzer, J. ; Meissner, J.-E. ; Goerke, S. ; Windschuh, J. ; Deike-Hofmann, K. ; Bickelhaupt, S. ; Zaiss, M. ; Radbruch, A. ; Bendszus, M. ; Wick, W. ; Unterberg, A. ; Rieken, S. ; Debus, J. ; Bachert, P. ; Ladd, M. ; Schlemmer, H.-P. ; Paech, D. (Last author)
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
OncoTarget 9(47), 28772-28783 (2018) [10.18632/oncotarget.25594]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Paech, D. (First author) ; Windschuh, J. ; Oberhollenzer, J. ; Dreher, C. ; Sahm, F. ; Meissner, J.-E. ; Goerke, S. ; Schuenke, P. ; Zaiss, M. ; Regnery, S. ; Bickelhaupt, S. ; Bäumer, P. ; Bendszus, M. ; Wick, W. ; Unterberg, A. ; Bachert, P. ; Ladd, M. ; Schlemmer, H.-P. ; Radbruch, A. (Last author)
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
Neuro-Oncology 20(12), 1661 - 1671 (2018) [10.1093/neuonc/noy073]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Louis, D. N. ; Giannini, C. ; Capper, D. ; Paulus, W. ; Figarella-Branger, D. ; Lopes, M. B. ; Batchelor, T. T. ; Cairncross, J. G. ; van den Bent, M. ; Wick, W. ; Wesseling, P.
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.
Acta neuropathologica 135(4), 639 - 642 (2018) [10.1007/s00401-018-1826-y]2018 BibTeX | EndNote: XML, Text | RIS

Friedrich, M. (First author) ; Bunse, L. ; Wick, W. ; Platten, M. (Last author)
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.
Current opinion in oncology 30(6), 368-374 (2018) [10.1097/CCO.0000000000000478]2018 BibTeX | EndNote: XML, Text | RIS

Burdyniuk, M. ; Wesolowska, N. ; Fleszar, M. ; Karreman, M. A. ; Machado, P. ; Borrego-Pinto, J. ; Ruthensteiner, B. ; Schwab, Y. ; Lénárt, P.
Correlated light and electron microscopy of cell division in large marine oocytes, eggs, and embryos.
Methods in cell biology 145, 293-313 (2018) [10.1016/bs.mcb.2018.03.031]2018 BibTeX | EndNote: XML, Text | RIS

Tejada Neyra, M. A. ; Neuberger, U. ; Reinhardt, A. ; Brugnara, G. ; Bonekamp, D. ; Sill, M. ; Wick, A. ; Jones, D. ; Radbruch, A. ; Unterberg, A. ; Debus, J. ; Heiland, S. ; Schlemmer, H.-P. ; Herold-Mende, C. ; Pfister, S. ; von Deimling, A. ; Wick, W. ; Capper, D. ; Bendszus, M. ; Kickingereder, P.
Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma.
Neuro-Oncology 20(11), 1517 - 1524 (2018) [10.1093/neuonc/noy134]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Ellingson, B. M. ; Abrey, L. E. ; Garcia, J. ; Chinot, O. ; Wick, W. ; Saran, F. ; Nishikawa, R. ; Henriksson, R. ; Mason, W. P. ; Harris, R. J. ; Leu, K. ; Woodworth, D. C. ; Mehta, A. ; Raymond, C. ; Chakhoyan, A. ; Pope, W. B. ; Cloughesy, T. F.
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
Neuro-Oncology 20(11), 1525 - 1535 (2018) [10.1093/neuonc/noy064]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Katz, L. M. ; Hielscher, T. (First author) ; Liechty, B. ; Silverman, J. ; Zagzag, D. ; Sen, R. ; Wu, P. ; Golfinos, J. G. ; Reuss, D. ; Neidert, M. C. ; Wirsching, H.-G. ; Baumgarten, P. ; Herold-Mende, C. ; Wick, W. ; Harter, P. ; Weller, M. ; von Deimling, A. ; Snuderl, M. ; Sen, C. ; Sahm, F. (Last author)
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
Acta neuropathologica 135(6), 955 - 963 (2018) [10.1007/s00401-018-1844-9]2018 BibTeX | EndNote: XML, Text | RIS

Karimian-Jazi, K. ; Wildemann, B. ; Diem, R. ; Schwarz, D. ; Hielscher, T. ; Wick, W. ; Bendszus, M. ; Breckwoldt, M. (Last author)
Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI.
Neurology 5(5), e480 (2018) [10.1212/NXI.0000000000000480]2018 DBCoverage Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Berberich, A. (First author) ; Hielscher, T. ; Kickingereder, P. ; Winkler, F. ; Drüschler, K. ; Riedemann, L. ; Arzt, M. ; Kessler, T. ; Platten, M. ; von Deimling, A. ; Wick, W. ; Sahm, F. ; Bendszus, M. ; Wick, A.
Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma Patients.
International journal of radiation oncology, biology, physics 102(5), 1472 - 1480 (2018) [10.1016/j.ijrobp.2018.07.2004]2018 BibTeX | EndNote: XML, Text | RIS

Sievers, P. (First author) ; Stichel, D. ; Hielscher, T. ; Schrimpf, D. ; Reinhardt, A. ; Wefers, A. K. ; Reuss, D. ; Jones, D. ; Bewerunge-Hudler, M. ; Hartmann, C. ; Baumgarten, P. ; Wirsching, H.-G. ; Winther-Kristensen, B. ; Brokinkel, B. ; Ketter, R. ; Idoate Gastearena, M. A. ; Lamszus, K. ; Seiz-Rosenhagen, M. ; Mawrin, C. ; Harter, P. ; Felsberg, J. ; Hänggi, D. ; Herold-Mende, C. ; Berghoff, A. S. ; Weller, M. ; Pfister, S. ; Wick, W. ; Reifenberger, G. ; Preusser, M. ; von Deimling, A. ; Sahm, F. (Last author)
Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p.1
Acta neuropathologica 136(6), 975-978 (2018) [10.1007/s00401-018-1924-x]2018 BibTeX | EndNote: XML, Text | RIS

Wick, W. (First author) ; van den Bent, M. J.
First results on the DCVax phase III trial: raising more questions than providing answers.
Neuro-Oncology 20(10), 1283 - 1284 (2018) [10.1093/neuonc/noy125]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Wick, W. (First author) ; Platten, M. (Last author)
Understanding and Treating Glioblastoma.
Neurologic clinics 36(3), 485 - 499 (2018) [10.1016/j.ncl.2018.04.006]2018 BibTeX | EndNote: XML, Text | RIS

Stichel, D. (First author) ; Ebrahimi, A. (First author) ; Reuss, D. ; Schrimpf, D. ; Ono, T. ; Shirahata, M. ; Reifenberger, G. ; Weller, M. ; Hänggi, D. ; Wick, W. ; Herold-Mende, C. ; Westphal, M. ; Brandner, S. ; Pfister, S. ; Capper, D. ; Sahm, F. ; von Deimling, A. (Last author)
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
Acta neuropathologica 136(5), 793-803 (2018) [10.1007/s00401-018-1905-0]2018 BibTeX | EndNote: XML, Text | RIS

Le Rhun, E. ; Genbrugge, E. ; Stupp, R. ; Chinot, O. L. ; Nabors, L. B. ; Cloughesy, T. ; Reardon, D. A. ; Wick, W. ; Gorlia, T. ; Weller, M.
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.
European journal of cancer 101, 95 - 104 (2018) [10.1016/j.ejca.2018.06.029]2018 BibTeX | EndNote: XML, Text | RIS

Winkler, F. (Last author)
Leukaemia follows a blood-vessel track to enter the nervous system
Nature <London> 560(7716), 35 - 36 (2018) [10.1038/d41586-018-05693-x]2018 BibTeX | EndNote: XML, Text | RIS

Wick, W. (First author) ; Osswald, M. ; Wick, A. ; Winkler, F. (Last author)
Treatment of glioblastoma in adults.
Therapeutic advances in neurological disorders 11, 1756286418790452 (2018) [10.1177/1756286418790452]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Wick, W. (First author) ; Kessler, T. (Last author)
New glioblastoma heterogeneity atlas - a shared resource.
Nature reviews / Neurology 14(8), 453 - 454 (2018) [10.1038/s41582-018-0038-3]2018 BibTeX | EndNote: XML, Text | RIS

Ellingson, B. M. ; Abrey, L. E. ; Nelson, S. J. ; Kaufmann, T. J. ; Garcia, J. ; Chinot, O. ; Saran, F. ; Nishikawa, R. ; Henriksson, R. ; Mason, W. P. ; Wick, W. ; Butowski, N. ; Ligon, K. L. ; Gerstner, E. R. ; Colman, H. ; de Groot, J. ; Chang, S. ; Mellinghoff, I. ; Young, R. J. ; Alexander, B. M. ; Colen, R. ; Taylor, J. W. ; Arrillaga-Romany, I. ; Mehta, A. ; Huang, R. Y. ; Pope, W. B. ; Reardon, D. ; Batchelor, T. ; Prados, M. ; Galanis, E. ; Wen, P. Y. ; Cloughesy, T. F.
Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.
Neuro-Oncology 20(9), 1240 - 1250 (2018) [10.1093/neuonc/noy053]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Wirthschaft, P. (First author) ; Bode, J. ; Simon, A. ; Hoffmann, E. ; van Laack, R. ; Krüwel, T. ; Dietrich, F. ; Bucher, D. ; Hahn, A. ; Sahm, F. ; Breckwoldt, M. ; Kurz, F. T. ; Hielscher, T. ; Fischer, B. ; Dross, N. ; Ruiz de Almodovar, C. ; von Deimling, A. ; Herold-Mende, C. ; Plass, C. ; Boulant, S. ; Wiestler, B. P. O. ; Reifenberger, G. ; Lichter, P. ; Wick, W. ; Tews, B. (Last author)
A PRDX1-p38? heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.
International journal of cancer 143(5), 1176 - 1187 (2018) [10.1002/ijc.31404]2018 BibTeX | EndNote: XML, Text | RIS

Valiente, M. ; Ahluwalia, M. S. ; Boire, A. ; Brastianos, P. K. ; Goldberg, S. B. ; Lee, E. Q. ; Le Rhun, E. ; Preusser, M. ; Winkler, F. ; Soffietti, R.
The Evolving Landscape of Brain Metastasis.
Trends in cancer 4(3), 176 - 196 (2018) [10.1016/j.trecan.2018.01.003]2018 BibTeX | EndNote: XML, Text | RIS

Shirahata, M. ; Ono, T. ; Stichel, D. (First author) ; Schrimpf, D. ; Reuss, D. E. ; Sahm, F. ; Koelsche, C. ; Wefers, A. ; Reinhardt, A. ; Huang, K. ; Sievers, P. ; Shimizu, H. ; Nanjo, H. ; Kobayashi, Y. ; Miyake, Y. ; Suzuki, T. ; Adachi, J.-I. ; Mishima, K. ; Sasaki, A. ; Nishikawa, R. ; Bewerunge-Hudler, M. ; Ryzhova, M. ; Absalyamova, O. ; Golanov, A. ; Sinn, P. ; Platten, M. ; Jungk, C. ; Winkler, F. ; Wick, A. ; Hänggi, D. ; Unterberg, A. ; Pfister, S. ; Jones, D. ; van den Bent, M. ; Hegi, M. ; French, P. ; Baumert, B. G. ; Stupp, R. ; Gorlia, T. ; Weller, M. ; Capper, D. ; Korshunov, A. ; Herold-Mende, C. ; Wick, W. ; Louis, D. N. ; von Deimling, A. (Last author)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Acta neuropathologica 136(1), 153 - 166 (2018) [10.1007/s00401-018-1849-4]2018 BibTeX | EndNote: XML, Text | RIS

Capper, D. (First author) ; Stichel, D. ; Sahm, F. ; Jones, D. ; Schrimpf, D. ; Sill, M. ; Schmid, S. ; Hovestadt, V. ; Reuss, D. E. ; Koelsche, C. ; Reinhardt, A. ; Wefers, A. K. ; Huang, K. ; Sievers, P. ; Ebrahimi, A. ; Schöler, A. ; Teichmann, D. ; Koch, A. ; Hänggi, D. ; Unterberg, A. ; Platten, M. ; Wick, W. ; Witt, O. ; Milde, T. ; Korshunov, A. ; Pfister, S. ; von Deimling, A. (Last author)
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.
Acta neuropathologica 136(2), 181 - 210 (2018) [10.1007/s00401-018-1879-y]2018 BibTeX | EndNote: XML, Text | RIS

Buschle, L. (First author) ; Ziener, C. ; Zhang, K. ; Sturm, V. ; Kampf, T. ; Hahn, A. ; Solecki, G. M. ; Winkler, F. ; Bendszus, M. ; Heiland, S. ; Schlemmer, H.-P. ; Kurz, F. T. (Last author)
Vessel radius mapping in an extended model of transverse relaxation.
Magnetic resonance materials in physics, biology and medicine 31(4), 531 - 551 (2018) [10.1007/s10334-018-0677-9]2018 BibTeX | EndNote: XML, Text | RIS

Wick, W. (First author) ; Winkler, F. (Last author)
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
Cancer 124(13), 2674 - 2676 (2018) [10.1002/cncr.31371]2018 BibTeX | EndNote: XML, Text | RIS

Pfaff, E. (First author) ; Kessler, T. (First author) ; Balasubramanian, G. P. ; Berberich, A. ; Schrimpf, D. ; Wick, A. ; Debus, J. ; Unterberg, A. ; Bendszus, M. ; Herold-Mende, C. ; Capper, D. ; Schenkel, I. ; Eisenmenger, A. ; Dettmer, S. ; Brors, B. ; Platten, M. ; Pfister, S. ; von Deimling, A. ; Jones, D. (Last author) ; Wick, W. (Last author) ; Sahm, F. (Last author)
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.
Neuro-Oncology 20(6), 826 - 837 (2018) [10.1093/neuonc/nox216]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Kickingereder, P. ; Neuberger, U. ; Bonekamp, D. ; Piechotta, P. L. ; Götz, M. ; Wick, A. ; Sill, M. ; Kratz, A. ; Shinohara, R. T. ; Jones, D. ; Radbruch, A. ; Muschelli, J. ; Unterberg, A. ; Debus, J. ; Schlemmer, H.-P. ; Herold-Mende, C. ; Pfister, S. ; von Deimling, A. ; Wick, W. ; Capper, D. ; Maier-Hein, K. (Last author) ; Bendszus, M.
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
Neuro-Oncology 20(6), 848 - 857 (2018) [10.1093/neuonc/nox188]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Platten, M. (First author) ; Bunse, L. ; Riehl, D. ; Bunse, T. ; Ochs, K. ; Wick, W. (Last author)
Vaccine Strategies in Gliomas.
Current treatment options in neurology 20(5), 11 (2018) [10.1007/s11940-018-0498-1]2018 BibTeX | EndNote: XML, Text | RIS

Debus, C. (First author) ; Waltenberger, M. ; Floca, R. ; Afshar-Oromieh, A. ; Bougatf, N. ; Adeberg, S. ; Heiland, S. ; Bendszus, M. ; Wick, W. ; Rieken, S. ; Haberkorn, U. ; Debus, J. ; Knoll, M. ; Abdollahi, A. (Last author)
Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.
Scientific reports 8(1), 7201 (2018) [10.1038/s41598-018-25350-7]2018 DBCoverage Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Blaes, J. (First author) ; Thome, C. (First author) ; Pfenning, P.-N. ; Rübmann, P. ; Sahm, F. ; Wick, A. ; Bunse, T. ; Schmenger, T. ; Sykora, J. ; von Deimling, A. ; Wiestler, B. P. O. ; Merz, C. ; Jugold, M. ; Haberkorn, U. ; Abdollahi, A. ; Debus, J. ; Gieffers, C. ; Kunz, C. ; Bendszus, M. ; Kluge, M. ; Platten, M. ; Fricke, H. ; Wick, W. ; Lemke, D. (Last author)
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.
Molecular cancer research 16(5), 767 - 776 (2018) [10.1158/1541-7786.MCR-17-0563]2018 BibTeX | EndNote: XML, Text | RIS

Winkler, F. (First author) ; Osswald, M. ; Wick, W. (Last author)
Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.
Oncology research and treatment 41(4), 181 - 186 (2018) [10.1159/000488258]2018 BibTeX | EndNote: XML, Text | RIS

Nowosielski, M. (First author) ; Ellingson, B. M. ; Chinot, O. L. ; Garcia, J. ; Revil, C. ; Radbruch, A. ; Nishikawa, R. ; Mason, W. P. ; Henriksson, R. ; Saran, F. ; Kickingereder, P. ; Platten, M. ; Sandmann, T. ; Abrey, L. E. ; Cloughesy, T. F. ; Bendszus, M. ; Wick, W. (Last author)
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio.
Neuro-Oncology 20(4), 557 - 566 (2018) [10.1093/neuonc/nox162]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Follain, G. ; Osmani, N. ; Azevedo, A. S. ; Allio, G. ; Mercier, L. ; Karreman, M. A. ; Solecki, G. M. ; Garcia Leòn, M. J. ; Lefebvre, O. ; Fekonja, N. ; Hille, C. ; Chabannes, V. ; Dollé, G. ; Metivet, T. ; Hovsepian, F. D. ; Prudhomme, C. ; Pichot, A. ; Paul, N. ; Carapito, R. ; Bahram, S. ; Ruthensteiner, B. ; Kemmling, A. ; Siemonsen, S. ; Schneider, T. ; Fiehler, J. ; Glatzel, M. ; Winkler, F. ; Schwab, Y. ; Pantel, K. ; Harlepp, S. ; Goetz, J. G.
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells.
Developmental cell 45(1), 33 - 52.e12 (2018) [10.1016/j.devcel.2018.02.015]2018 BibTeX | EndNote: XML, Text | RIS

Reitman, Z. J. ; Winkler, F. ; Elia, A. E. H.
New Directions in the Treatment of Glioblastoma.
Seminars in neurology 38(1), 050 - 061 (2018) [10.1055/s-0038-1623534]2018 BibTeX | EndNote: XML, Text | RIS

Batchelor, T. ; Wick, W. (Last author)
Neuro-Oncology
Seminars in neurology 38(01), 003 - 004 (2018) [10.1055/s-0038-1635105]2018 BibTeX | EndNote: XML, Text | RIS

Piechotta, P. L. ; Bonekamp, D. ; Sill, M. ; Wick, A. ; Wick, W. ; Bendszus, M. ; Kickingereder, P.
Increased Delay Between Gadolinium Chelate Administration and T1-Weighted Magnetic Resonance Imaging Acquisition Increases Contrast-Enhancing Tumor Volumes and T1 Intensities in Brain Tumor Patients.
Investigative radiology 53(4), 223 - 228 (2018) [10.1097/RLI.0000000000000432]2018 BibTeX | EndNote: XML, Text | RIS

Berghoff, A. S. (First author) ; Brastianos, P. K.
Toward Precision Medicine in Brain Metastases.
Seminars in neurology 38(1), 095 - 103 (2018) [10.1055/s-0038-1627469]2018 BibTeX | EndNote: XML, Text | RIS

Bady, P. ; Kurscheid, S. ; Delorenzi, M. ; Gorlia, T. ; van den Bent, M. J. ; Hoang-Xuan, K. ; Vauléon, É. ; Gijtenbeek, A. ; Enting, R. ; Thiessen, B. ; Chinot, O. ; Dhermain, F. ; Brandes, A. A. ; Reijneveld, J. C. ; Marosi, C. ; Taphoorn, M. J. B. ; Wick, W. ; von Deimling, A. ; French, P. ; Stupp, R. ; Baumert, B. G. ; Hegi, M. E.
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
Acta neuropathologica 135(4), 601 - 615 (2018) [10.1007/s00401-018-1810-6]2018 BibTeX | EndNote: XML, Text | RIS

Louis, D. N. ; Wesseling, P. ; Paulus, W. ; Giannini, C. ; Batchelor, T. T. ; Cairncross, J. G. ; Capper, D. ; Figarella-Branger, D. ; Lopes, M. B. ; Wick, W. ; van den Bent, M.
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).
Acta neuropathologica 135(3), 481 - 484 (2018) [10.1007/s00401-018-1808-0]2018 BibTeX | EndNote: XML, Text | RIS

Longuespée, R. ; Wefers, A. K. (First author) ; De Vita, E. ; Miller, A. ; Reuss, D. E. ; Wick, W. ; Herold-Mende, C. ; Kriegsmann, M. ; Schirmacher, P. ; von Deimling, A. (Last author) ; Pusch, S. (Last author)
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry.
Acta Neuropathologica Communications 6(1), 21 (2018) [10.1186/s40478-018-0523-3]2018 DBCoverage Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Kessler, T. (First author) ; Sahm, F. ; Sadik, A. ; Stichel, D. ; Hertenstein, A. ; Reifenberger, G. ; Zacher, A. ; Sabel, M. ; Tabatabai, G. ; Steinbach, J. ; Sure, U. ; Krex, D. ; Grosu, A.-L. ; Bewerunge-Hudler, M. ; Jones, D. ; Pfister, S. ; Weller, M. ; Opitz, C. ; Bendszus, M. ; von Deimling, A. ; Platten, M. ; Wick, W. (Last author)
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Neuro-Oncology 20(3), 367 - 379 (2018) [10.1093/neuonc/nox160]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Wick, A. (First author) ; Kessler, T. ; Elia, A. E. H. ; Winkler, F. ; Batchelor, T. T. ; Platten, M. ; Wick, W. (Last author)
Glioblastoma in elderly patients: solid conclusions built on shifting sand?
Neuro-Oncology 20(2), 174 - 183 (2018) [10.1093/neuonc/nox133]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Beier, D. ; Proescholdt, M. ; Reinert, C. ; Pietsch, T. ; Jones, D. ; Pfister, S. ; Hattingen, E. ; Seidel, C. ; Dirven, L. ; Luerding, R. ; Reijneveld, J. ; Warmuth-Metz, M. ; Bonsanto, M. ; Bremer, M. ; Combs, S. E. ; Rieken, S. ; Herrlinger, U. ; Kuntze, H. ; Mayer-Steinacker, R. ; Moskopp, D. ; Schneider, T. ; Beringer, A. ; Schlegel, U. ; Stummer, W. ; Welker, H. ; Weyerbrock, A. ; Paulsen, F. ; Rutkowski, S. ; Weller, M. ; Wick, W. ; Kortmann, R.-D. ; Bogdahn, U. ; Hau, P.
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20(3), 400 - 410 (2018) [10.1093/neuonc/nox155]2018 pmc Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

Wick, W. (First author) ; Kessler, T. (Last author)
Drug Repositioning Meets Precision in Glioblastoma.
Clinical cancer research 24(2), 256 - 258 (2018) [10.1158/1078-0432.CCR-17-2989]2018 BibTeX | EndNote: XML, Text | RIS

powered by webEdition CMS